UroGen Pharma Ltd. (URGN) › Gross ProfitUroGen Pharma Ltd. (URGN) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2016: $17.50M2017: $7.56M2018: -$675.0K2019: $18.0K2020: $10.79M2021: $42.88M2022: $56.70M2023: $73.35M2024: $81.52M2025: $97.34M$97.34M2016Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$97.34M+19.4%2024$81.52M+11.1%2023$73.35M+29.4%2022$56.70M+32.2%2021$42.88M+297.5%2020$10.79M+59844.4%2019$18.0K+102.7%2018-$675.0K-108.9%2017$7.56M-56.8%2016$17.50M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share